Literature DB >> 21349932

Reinnervation of the paralyzed diaphragm: application of nerve surgery techniques following unilateral phrenic nerve injury.

Matthew R Kaufman1, Andrew I Elkwood2, Michael I Rose2, Tushar Patel2, Russell Ashinoff2, Adam Saad3, Robert Caccavale4, Jean-Philippe Bocage4, Jeffrey Cole5, Aida Soriano6, Ed Fein7.   

Abstract

BACKGROUND: Unilateral phrenic nerve injury often results in symptomatic hemidiaphragm paralysis, and currently few treatment options exist. Reported etiologies include cardiac surgery, neck surgery, chiropractic manipulation, and interscalene nerve blocks. Although diaphragmatic plication has been an option for treatment, the ideal treatment would be restoration of function to the paralyzed hemidiaphragm. The application of peripheral nerve surgery techniques for phrenic nerve injuries has not been adequately evaluated.
METHODS: Twelve patients presenting with long-term, symptomatic, unilateral phrenic nerve injuries following surgery, chiropractic manipulation, trauma, or anesthetic blocks underwent a comprehensive evaluation, including radiographic and electrophysiologic assessments. Surgical treatment was offered following a minimum of 6 months of conservative management. Operative planning was based on preoperative and intraoperative testing using one or more established nerve reconstruction techniques (neurolysis, interpositional grafting, or neurotization).
RESULTS: Measures of postoperative improvement included pulmonary function testing, fluoroscopic sniff testing, and a standardized quality-of-life survey, from which it was determined that eight of nine patients who could be completely evaluated experienced improvements in diaphragmatic function.
CONCLUSIONS: Based on the favorable results in this small series, we suggest expanding nerve reconstruction techniques to phrenic nerve injury treatment and propose an algorithm for treatment of unilateral phrenic nerve injury that may expand the current limitations in therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21349932     DOI: 10.1378/chest.10-2765

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Phrenic nerve stimulation during neck dissection for advanced thyroid cancer involving level IV: is it worth doing it?

Authors:  Carlos S Duque; Juan P Dueñas; Marcela Marulanda; Diana Pérez; Andres Londoňo; Soham Roy; Mai Al Khadem
Journal:  Updates Surg       Date:  2017-02-13

Review 2.  Neuromuscular ultrasound for evaluation of the diaphragm.

Authors:  Aarti Sarwal; Francis O Walker; Michael S Cartwright
Journal:  Muscle Nerve       Date:  2013-02-04       Impact factor: 3.217

3.  Early hemi-diaphragmatic plication through a video assisted mini-thoracotomy in postcardiotomy phrenic nerve paresis.

Authors:  Kosmas Tsakiridis; Aikaterini N Visouli; Paul Zarogoulidis; Nikolaos Machairiotis; Christos Christofis; Aikaterini Stylianaki; Nikolaos Katsikogiannis; Andreas Mpakas; Nicolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2012-11       Impact factor: 2.895

4.  Treatment for bilateral diaphragmatic dysfunction using phrenic nerve reconstruction and diaphragm pacemakers.

Authors:  Matthew R Kaufman; Thomas Bauer; Raymond P Onders; David P Brown; Eric I Chang; Kristie Rossi; Andrew I Elkwood; Ethan Paulin; Reza Jarrahy
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-10

5.  Electromyographic permutation entropy quantifies diaphragmatic denervation and reinnervation.

Authors:  Christopher Kramer; Denis Jordan; Alexander Kretschmer; Veronika Lehmeyer; Kristine Kellermann; Stephan J Schaller; Manfred Blobner; Eberhard F Kochs; Heidrun Fink
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

6.  Importance of muldisciplinary management of giant mediastinal sarcoma: A case report with phrenic nerve reconstruction.

Authors:  Luca Frasca; Filippo Longo; Giovanni Tacchi; Francesco Stilo; Anna Zito; Beniamino Brunetti; Massimiliano Depalma; Pierfilippo Crucitti
Journal:  Thorac Cancer       Date:  2020-04-23       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.